• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Kozak 基因多态性对费城阴性 MPN 患者血栓形成的预测价值。

Predictive Value of Kozak Gene Polymorphism for Thrombosis in Patients with Philadelphia-Negative MPNs.

机构信息

Hematology Unit, Department of Clinical Pathology, Faculty of Medicine, Mansoura University, Mansoura, Egypt.

Clinical Hematology Unit, Oncology Center Mansoura University, Faculty of Medicine, Mansoura, Egypt.

出版信息

Asian Pac J Cancer Prev. 2021 Apr 1;22(4):1195-1201. doi: 10.31557/APJCP.2021.22.4.1195.

DOI:10.31557/APJCP.2021.22.4.1195
PMID:33906312
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8325125/
Abstract

BACKGROUND

Philadelphia-negative myeloproliferative neoplasms (MPNs) including polycythemia vera (PV), essential thrombocythemia (ET) and myelofibrosis are clonal haematopoietic stem cell disorders characterized by dysregulated proliferation. The arterial and venous thromboses are the major causes of morbidity and mortality in MPNs. The platelet GP Ib-IX-V receptor complex plays an important role in thrombus formation as the Kozak sequence polymorphism of platelet GP Ibα is associated with increased receptor density.

MATERIALS AND METHODS

This study was conducted on 286 diagnosed patients with Ph-negative MPNs (94 patients of PV, 102 of ET and 90 of MF). In addition, 107 apparently healthy individuals served as a control group.

RESULTS

This study revealed that by taking rs2243093 TT as the reference genotype and T as the reference allele; TC, CC, TC+CC genotypes showed lower frequency in ET patients (p= 0.005, 0.007 and 0.001 respectively) and MF patients (p= 0.002, 0.047 and 0.001 respectively) when compared to control groups also, C allele in both groups compared to control (p ≤ 0.001 both). CC genotypes and C allele showed lower frequency in PV patients when compared to control groups (p= 0.032 and 0.026 respectively).

CONCLUSION

From this study we could conclude that patients with Philadelphia-negative MPNs carried Kozak gene polymorphism significantly TT genotype in all patients PV, ET, MF patients and TC in ET and MF patients. The platelet glycoprotein Ibα (Kozak) gene could be incorporated into the routine workup to predict venous thrombosis in patients with Ph-negative MPNs specially ET patients.

摘要

背景

费城阴性骨髓增殖性肿瘤(MPN)包括真性红细胞增多症(PV)、特发性血小板增多症(ET)和骨髓纤维化,是一种克隆性造血干细胞疾病,其特征是增殖失调。动脉和静脉血栓形成是 MPN 发病和死亡的主要原因。血小板 GP Ib-IX-V 受体复合物在血栓形成中起重要作用,因为血小板 GP Ibα 的 Kozak 序列多态性与受体密度增加有关。

材料和方法

本研究共纳入 286 例诊断为 Ph 阴性 MPN 的患者(94 例 PV、102 例 ET 和 90 例 MF),另外 107 例健康个体作为对照组。

结果

本研究表明,以 rs2243093 TT 为参考基因型,T 为参考等位基因;TC、CC 基因型在 ET 患者(p=0.005、0.007 和 0.001)和 MF 患者(p=0.002、0.047 和 0.001)中的频率较低,与对照组相比,C 等位基因在两组中均较低(p≤0.001)。与对照组相比,CC 基因型和 C 等位基因在 PV 患者中频率较低(p=0.032 和 0.026)。

结论

从本研究中我们可以得出结论,所有 PV、ET 和 MF 患者的 Koza 基因多态性均为 TT 基因型,ET 和 MF 患者的 TC 基因型,血小板糖蛋白 Ibα(Kozak)基因可纳入常规检查,以预测 Ph 阴性 MPN 患者,特别是 ET 患者的静脉血栓形成。

相似文献

1
Predictive Value of Kozak Gene Polymorphism for Thrombosis in Patients with Philadelphia-Negative MPNs.Kozak 基因多态性对费城阴性 MPN 患者血栓形成的预测价值。
Asian Pac J Cancer Prev. 2021 Apr 1;22(4):1195-1201. doi: 10.31557/APJCP.2021.22.4.1195.
2
Thrombosis in the Philadelphia Chromosome-Negative Myeloproliferative Neoplasms.费城染色体阴性骨髓增殖性肿瘤中的血栓形成
Cancer Treat Res. 2019;179:159-178. doi: 10.1007/978-3-030-20315-3_11.
3
Clinical Manifestations and Risk Factors for Complications of Philadelphia Chromosome-Negative Myeloproliferative Neoplasms.费城染色体阴性骨髓增殖性肿瘤的临床表现及并发症危险因素
Asian Pac J Cancer Prev. 2015;16(12):5013-8. doi: 10.7314/apjcp.2015.16.12.5013.
4
Thrombosis among 1537 patients with JAK2 -mutated myeloproliferative neoplasms: Risk factors and development of a predictive model.1537 例 JAK2 突变骨髓增殖性肿瘤患者的血栓形成:危险因素和预测模型的建立。
Cancer Med. 2020 Mar;9(6):2096-2105. doi: 10.1002/cam4.2886. Epub 2020 Jan 28.
5
Epidemiology of the Philadelphia Chromosome-Negative Classical Myeloproliferative Neoplasms.费城染色体阴性经典骨髓增殖性肿瘤的流行病学。
Hematol Oncol Clin North Am. 2021 Apr;35(2):177-189. doi: 10.1016/j.hoc.2020.11.005. Epub 2021 Jan 4.
6
The evolving understanding of prognosis in post-essential thrombocythemia myelofibrosis and post-polycythemia vera myelofibrosis vs primary myelofibrosis.真性红细胞增多症后骨髓纤维化和原发性血小板增多症后骨髓纤维化与原发性骨髓纤维化的预后的逐步认识。
Clin Adv Hematol Oncol. 2019 May;17(5):299-307.
7
Study on the Clinical Significance of JAK2V617F Allele Burden in Philadelphia Chromosome-Negative Myeloproliferative Neoplasm.JAK2V617F等位基因负荷在费城染色体阴性骨髓增殖性肿瘤中的临床意义研究
Clin Lab. 2016 Aug 1;62(8):1477-1481. doi: 10.7754/Clin.Lab.2016.151208.
8
[Significance of the JAK2V617F mutation in patients with chronic myeloproliferative neoplasia].[JAK2V617F突变在慢性骨髓增殖性肿瘤患者中的意义]
Orv Hetil. 2011 Nov 6;152(45):1795-803. doi: 10.1556/OH.2011.29226.
9
p.(V617F) mutation in Tunisian myeloproliferative neoplasms and its genotype-phenotype correlation.(V617F)突变在突尼斯骨髓增殖性肿瘤及其与基因型-表型相关性。
Pan Afr Med J. 2021 Jul 12;39:194. doi: 10.11604/pamj.2021.39.194.28307. eCollection 2021.
10
Leukocytosis and MPNs: Where do we stand?白细胞增多症与骨髓增殖性肿瘤:我们目前的状况如何?
Leuk Lymphoma. 2023 Mar;64(3):564-572. doi: 10.1080/10428194.2022.2156794. Epub 2022 Dec 15.

引用本文的文献

1
Proteomic-Based Platelet Activation-Associated Protein SELP May Be a Novel Biomarker for Coagulation and Prognostic in Essential Thrombocythemia.基于蛋白质组学的血小板活化相关蛋白SELP可能是原发性血小板增多症凝血和预后的新型生物标志物。
J Clin Med. 2023 Jan 30;12(3):1078. doi: 10.3390/jcm12031078.

本文引用的文献

1
Thrombotic, inflammatory, and HIF-regulated genes and thrombosis risk in polycythemia vera and essential thrombocythemia.真性红细胞增多症和原发性血小板增多症中的血栓形成、炎症和低氧诱导因子调节基因与血栓形成风险
Blood Adv. 2020 Mar 24;4(6):1115-1130. doi: 10.1182/bloodadvances.2019001379.
2
Risk factors and incidence of thrombosis in a Brazilian cohort of patients with Philadelphia-negative myeloproliferative neoplasms.巴西费城阴性骨髓增殖性肿瘤患者队列的血栓形成风险因素和发生率。
J Thromb Thrombolysis. 2020 May;49(4):667-672. doi: 10.1007/s11239-019-02029-y.
3
Influence of Blood Count, Cardiovascular Risks, Inherited Thrombophilia, and JAK2 V617F Burden Allele on Type of Thrombosis in Patients With Philadelphia Chromosome Negative Myeloproliferative Neoplasms.血细胞计数、心血管风险、遗传性血栓形成倾向、JAK2 V617F 负荷等位基因对费城染色体阴性骨髓增殖性肿瘤患者血栓类型的影响。
Clin Lymphoma Myeloma Leuk. 2019 Jan;19(1):53-63. doi: 10.1016/j.clml.2018.08.020. Epub 2018 Sep 10.
4
The 2016 revision of WHO classification of myeloproliferative neoplasms: Clinical and molecular advances.《世界卫生组织髓系增殖性肿瘤分类(2016年修订版):临床与分子进展》
Blood Rev. 2016 Nov;30(6):453-459. doi: 10.1016/j.blre.2016.06.001. Epub 2016 Jun 11.
5
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.2016 年版世界卫生组织髓系肿瘤和急性白血病分类。
Blood. 2016 May 19;127(20):2391-405. doi: 10.1182/blood-2016-03-643544. Epub 2016 Apr 11.
6
The JAK2 V617F mutational status and allele burden may be related with the risk of venous thromboembolic events in patients with Philadelphia-negative myeloproliferative neoplasms.JAK2 V617F 突变状态和等位基因负担可能与费城阴性骨髓增殖性肿瘤患者发生静脉血栓栓塞事件的风险相关。
Thromb Res. 2015 Feb;135(2):272-80. doi: 10.1016/j.thromres.2014.11.006. Epub 2014 Nov 15.
7
CALR vs JAK2 vs MPL-mutated or triple-negative myelofibrosis: clinical, cytogenetic and molecular comparisons.CALR 突变与 JAK2 突变、MPL 突变或三阴性骨髓纤维化的临床、细胞遗传学和分子比较。
Leukemia. 2014 Jul;28(7):1472-7. doi: 10.1038/leu.2014.3. Epub 2014 Jan 9.
8
Myeloproliferative neoplasms and thrombosis.骨髓增殖性肿瘤与血栓。
Blood. 2013 Sep 26;122(13):2176-84. doi: 10.1182/blood-2013-03-460154. Epub 2013 Jul 3.
9
Development and validation of an International Prognostic Score of thrombosis in World Health Organization-essential thrombocythemia (IPSET-thrombosis).国际预后评分血栓形成在世界卫生组织原发性血小板增多症(IPSET-thrombosis)中的开发和验证。
Blood. 2012 Dec 20;120(26):5128-33; quiz 5252. doi: 10.1182/blood-2012-07-444067. Epub 2012 Oct 1.
10
The impact of platelet membrane glycoprotein Ib alpha and Ia/IIa polymorphisms on the risk of thrombosis in the antiphospholipid syndrome.血小板膜糖蛋白 Ibα和 Ia/IIa 多态性对抗磷脂综合征血栓形成风险的影响。
Thromb Res. 2012 Apr;129(4):486-91. doi: 10.1016/j.thromres.2011.10.005. Epub 2011 Oct 28.